Linked Life Data

19051738

Source:http://linkedlifedata.com/resource/pubmed/id/19051738

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-12-4
pubmed:abstractText
Inhaled nitric oxide (NO) therapy is a measure to improve pulmonary hypertension and ventilation-perfusion inequality by administering NO gas. Basic studies suggest that low concentrations of inhaled NO decreases the increased pulmonary capillary pressure, depresses the increased permeability of pulmonary vasculature, inhibits the increased agglutination and adhesion of leucocytes to the lungs, depresses the increased agglutination and adhesion of platelets, and decreases the hypertensive remodeling of pulmonary vasculature. In the emergency and critical care settings, quite a lot of life-threatening patients with the exacerbation of pulmonary hypertension and/or hypoxemia by trauma, surgery and infections are admitted for treatment. In this paper, we discuss the present status of inhaled NO therapy from the point of view of an emergency and critical care physician.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0047-1852
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2169-73
pubmed:dateRevised
2011-7-27
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Inhaled nitric oxide therapy].
pubmed:affiliation
Department of Emergency and Intensive Care Medicine, Shinshu University School of Medicine.
pubmed:publicationType
Journal Article, English Abstract, Review